Read first-hand Astra Zeneca’s press release where they report that AstraZeneca’s first biologic respiratory medicine met primary and key secondary endpoints in pivotal trials for severe asthma.
Source: Benralizumab phase III trials show positive results in severe asthma
This drug is potentially a breakthrough for severe asthma.
At the moment, the standard treatment is steroids. But systemic steroid exposure can lead to serious and irreversible adverse effects, including osteoporosis, anxiety, depression, weight gain, glaucoma and diabetes.
If you suffer with asthma or have a friend or family member with this condition, this article might give them new hope.
Thoughts?
Dr Alf's Blog 